US Vice President Elect Kamala Harris Receives COVID-19 Shot

Washington: US Vice President Elect Kamala Harris received a live broadcast of a COVID-19 vaccination on television on Tuesday (December 29) as the upcoming Biden administration attempts to promote the warning, while the warning will be months before it becomes available to all.

Senator Harris, Who is Black and Asian-American, will become the second high-profile person from an ethnic minority background to receive the vaccine after Surgeon General Jerome Adams on 18 December.
Democratic presidential election Joe Biden, Who takes office on January 20, has said he will fight against the coronovirus, which has infected more than 19 million Americans and killed more than 334,000, his top priority. that The vaccine received its first injection dose live on television last week. Two doses are required for complete protection.

The Biden team has particularly emphasized the importance of encouraging vaccine delivery and vaccination in non-white groups killed by coronoviruses.
Harris received Modern Inc. COVID-19 Vaccine from a nurse wearing a mask and a face cap at a medical center in predominantly black southeast Washington. “I barely felt it,” Harris said, laughing, after receiving an injection in his upper left hand.

“I want to encourage everyone to get vaccinated – it’s relatively painless … it’s safe … it’s literally about saving lives. I trust scientists.”

Biden is scheduled to give an update on the epidemic in Wilvington, Delaware, later on Tuesday (December 29) following a briefing with his COVID-19 advisory team and warned that the infection rate and number of deaths in the coming weeks Is expected to increase. , An official of his transition team said.

“He will be truthful and straightforward with the American people who lie ahead and will tell the current administration to fall short of the pace of vaccination. He will also plan to get people vaccinated as soon as possible,” the official said. The officer said. Speaking on condition of anonymity.

Outgoing republican President Donald Trump, Who had COVID-19 in October, has often downplayed the severity of the epidemic and in response to a backlash that many health experts say was disorganized, cavalier and sometimes ignored the science behind disease transmission.

Biden will inherit the logistic challenges of distributing the vaccine to hundreds of millions of Americans, as well as persuade those who worry about its development.

Biden and his team have warned that the vaccine will take time to roll out to the general population and urge people to listen to the advice of medical experts to avoid infection by coronaviruses.

A member of Biden’s COVID-19 Advisory Board, Drs. Atul Gawande told CBS News that the transition team still did not have all the information needed to understand the bottlenecks that hampered the delivery of the stitches.

He warned that the Trump administration may have raised unrealistic expectations that everyone who wanted to get vaccinated could by the end of June 2021.

He said, “The real picture is that it can be expected that it may fall before this … Enough people are being vaccinated that we are coming back to normal and before the summer the general public Actually getting access to the vaccine, ”he said.

Other Biden transition officials took such precautions.

Biden’s Dr. for Surgeon General. Vivek Murthy told NBC News last week that while it was possible that low-risk people would get the vaccine in late spring, it was more realistic to expect it to be midsummer or early. Fall before reaching the general population.

The United States has so far authorized two COVID-19 vaccines: one developed by Pfizer Inc. and German partner BioNTech SE and the other by Moderna. Others are being evaluated.

Separately on Tuesday (December 29), the Republican-controlled US Senate is expected to raise the coronavirus aid check for Americans to $ 2,000 by the Democratic-led House of Representatives on Monday following Trump’s rise.[nL1N2J90H3] Biden said he favors an increase from the already approved $ 600.

Related Articles

Back to top button